About NewLeaf Symbiotics
NewLeaf Symbiotics is a company based in St. Louis (United States) founded in 2011 by Stephen Kahn. NewLeaf Symbiotics has raised $181 million across 11 funding rounds from investors including SABIC, Bayer and Monsanto. NewLeaf Symbiotics has completed 1 acquisition, including Intuitive Genomics. NewLeaf Symbiotics offers products and services including TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, TS601 Biofungicide, and Terrasym 402 Peanut Biostimulant. NewLeaf Symbiotics operates in a competitive market with competitors including Pivot Bio, Ginkgo Bioworks, Kula Bio, BioConsortia and Pluton Biosciences, among others.
- Headquarter St. Louis, United States
- Founders Stephen Kahn
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Newleaf Symbiotics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$181 M (USD)
in 11 rounds
-
Latest Funding Round
$47.01 M (USD), Series D
Dec 12, 2023
-
Investors
SABIC
& 12 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NewLeaf Symbiotics
NewLeaf Symbiotics offers a comprehensive portfolio of products and services, including TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, TS601 Biofungicide, and Terrasym 402 Peanut Biostimulant.
Protects corn from pests like CRW to increase yields.
Enhances corn growth and yields through biological application.
Improves soybean productivity in various field conditions.
Controls fungal issues in soybean crops effectively.
Boosts peanut yields by enhancing soil and plant health.
Supports tomato transplant growth for better crop performance.
People of NewLeaf Symbiotics
Unlock access to complete
Funding Insights of NewLeaf Symbiotics
NewLeaf Symbiotics has successfully raised a total of $181M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $47.01 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NewLeaf Symbiotics
NewLeaf Symbiotics has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include SABIC, Bayer and Monsanto.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Otter Capital's activities.
|
Locked | Locked | Locked | |
|
Stage agnostic venture capital firm
|
Locked | Locked | Locked | |
|
Venture capital firm investing in life sciences sector
|
Locked | Locked | Locked |
Investor details for NewLeaf Symbiotics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NewLeaf Symbiotics
NewLeaf Symbiotics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Intuitive Genomics.
Investment portfolio details for NewLeaf Symbiotics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Custom bioinformatics solutions are provided for genome-scale data analysis.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for NewLeaf Symbiotics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NewLeaf Symbiotics
Detailed financials for NewLeaf Symbiotics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Newleaf Symbiotics Comparisons
Peer comparison for NewLeaf Symbiotics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NewLeaf Symbiotics
NewLeaf Symbiotics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot Bio, Ginkgo Bioworks, Kula Bio, BioConsortia and Pluton Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Manufacturer of microbial crop nutrition products
|
|
| Locked | Locked | Locked |
Microbial biotech solutions for enhancing crop yields are developed.
|
|
| Locked | Locked | Locked |
Assay-based microbial research services are offered for industrial applications.
|
Detailed competitors of NewLeaf Symbiotics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Newleaf Symbiotics
Complete news archive for NewLeaf Symbiotics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NewLeaf Symbiotics
NewLeaf Symbiotics was founded in 2011.
NewLeaf Symbiotics is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Brent Smith is the current CEO of NewLeaf Symbiotics.
NewLeaf Symbiotics is a funded company, having raised a total of $181M across 11 funding rounds to date.
NewLeaf Symbiotics was founded in 2011 and is based in St. Louis, United States. Operations focus on the agriculture sector, where crop inputs are developed using Pink Pigmented Facultative Methylotrophs (PPFMs), a family of naturally occurring beneficial plant bacteria. These inputs are applied to seeds at specified concentrations to support plant growth, vigor, health, and yield increases. The company serves farming applications through these microbial solutions.
NewLeaf Symbiotics's top competitors include Ginkgo Bioworks, Pivot Bio and Kula Bio.
NewLeaf Symbiotics offers TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, TS601 Biofungicide, and 2 more products and services.
NewLeaf Symbiotics has made 1 acquisition, including Intuitive Genomics.
NewLeaf Symbiotics has 13 investors. Key investors include SABIC, Bayer, Monsanto, Otter Capital, and S2G Ventures.